Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells

Beta-catenin (CTNNB1) induces Bmp expression in urogenital sinus epithelium and participates in prostatic bud initiation and patterning

(2013) Vatsal Mehta et al.   DEVELOPMENTAL BIOLOGY

Looking beyond the Wnt pathway for the deep nature of β-catenin

(2013) François Fagotto   EMBO REPORTS

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

(2013) Shingen Nakamura et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Current Therapeutic Strategy for Multiple Myeloma

(2013) Kenshi Suzuki   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Bone morphogenetic protein-2, -6, and -7 differently regulate osteogenic differentiation of human periodontal ligament stem cells

(2013) Sema S. Hakki et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS

Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts

(2012) Rongrong Zhang et al.   BONE

Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib

(2012) Maki Uyama et al.   GENES TO CELLS

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

(2011) E. C. Lee et al.   CLINICAL CANCER RESEARCH

Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis

(2011) Huaiping Yuan et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Single-Molecule Imaging of Bmp4 Dimerization on Human Periodontal Ligament Cells

(2011) H.-W. Mi et al.   JOURNAL OF DENTAL RESEARCH

Histone deacetylase inhibitors and periodontal bone loss

(2011) M. D. Cantley et al.   JOURNAL OF PERIODONTAL RESEARCH

Bortezomib induces osteoblast differentiation via Wnt-independent activation of  -catenin/TCF signaling

(2009) Y.-W. Qiang et al.   BLOOD

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

(2008) Angela Pennisi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms

(2008) J. Dai et al.   CANCER RESEARCH

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

(2008) P. Moreau et al.   HAEMATOLOGICA